Coverage
-
December 14, 2016
Braintree Laboratories lost its bid to keep false advertising claims brought by Ferring Pharmaceuticals over a colonoscopy preparation drug from being heard by a jury, after a Massachusetts federal judge determined Tuesday that Ferring is entitled to trial on its "accounting of profits" damage theory — for now.
3 other articles on this case.
View all »